A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation
- 1 July 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 48 (7), 1416-1423
- https://doi.org/10.1007/s10350-005-0052-6
Abstract
The effective management of fistulas in patients with Crohn's disease presents an extremely challenging problem. Mesenchymal adult stem cells extracted from certain tissues, such as adipose tissue, can differentiate into various cell types. Therefore, we have tried to use such cells to stimulate healing of Crohn's fistulas. We designed a prospective Phase I clinical trial, involving five patients with Crohn's disease, to test the feasibility and safety of autologous stem cells transplantation in the treatment of fistulas. We also studied the expression of various cell markers and the growth rates of the lipoaspirate-derived cells that were used for transplantation. One patient was excluded because of bacterial contamination of cultured cells. We inoculated nine fistulas in four patients with autologous adipose tissue-derived stem cells at Passage 3 or earlier. Eight inoculated fistulas were followed weekly for at least eight weeks. In six fistulas, the external opening was covered with epithelium at the end of Week 8, and, thus, these fistulas were considered healed (75 percent). In the other two fistulas, there was only incomplete closure of the external opening, with a decrease in output flow (not healed; 25 percent). No adverse effects were observed in any patient at the end of the follow-up period (minimum follow-up,12 months; maximum follow-up, 30 months; follow-up average, 22 months). To our knowledge, this is the first report of a clinical trial of cell therapy using autologous stem cells obtained from a lipoaspirate. Our results indicate that our protocol is feasible and safe for the treatment of fistulas in Crohn's disease. The number of patients included and the uncontrolled nature of Phase I clinical trials do not allow demonstration of the effectiveness of the treatment. However, the results of the present study encourage to perform further studies in Phase II.Keywords
This publication has 10 references indexed in Scilit:
- Adipose-derived adult stromal cells heal critical-size mouse calvarial defectsNature Biotechnology, 2004
- Risk to the coronary arteries of intracoronary stem cell infusion and G-CSF cytokine therapyThe Lancet, 2004
- American gastroenterological association medical position statement: perianal Crohn’s diseaseGastroenterology, 2003
- The Vulture and Stem CellsNew England Journal of Medicine, 2003
- Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapyInternational Journal of Colorectal Disease, 2003
- Can Human Hematopoietic Stem Cells Become Skin, Gut, or Liver Cells?New England Journal of Medicine, 2002
- Management of Internal Fistulas in Crohn's DiseaseInflammatory Bowel Diseases, 2002
- Myogenic Differentiation by Human Processed Lipoaspirate CellsPlastic and Reconstructive Surgery, 2002
- Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based TherapiesTissue Engineering, 2001
- Gracilis Transposition in Complicated Perianal Fistula and Unhealed Perineal Wounds in Crohn's DiseaseBritish Journal of Surgery, 2000